0001415889-16-006301.txt : 20160621 0001415889-16-006301.hdr.sgml : 20160621 20160621214420 ACCESSION NUMBER: 0001415889-16-006301 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160619 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-244-9990 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Mark Alan CENTRAL INDEX KEY: 0001677452 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 161725527 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-06212016_060609.xml X0306 4 2016-06-19 0001411685 VistaGen Therapeutics, Inc. VTGN 0001677452 Smith Mark Alan C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 3.49 2016-06-19 4 A 0 180000 0 A 2026-06-19 Common Stock 180000 180000 D The Reporting Person's ability to exercise 30,000 of the options reported herein is conditioned upon stockholder approval of an amendment to the Issuer's 2008 Stock Incentive Plan. 25% of the shares subject to the option shall vest on the one year anniversary of the Grant Date and 1/48th of the shares subject to the option shall vest monthly every month thereafter until all awarded shares are fully vested. /s/ Jerrold D. Dotson, Attorney-in-Fact 2016-06-21